NAVROGEN INC
Summary
antibody-drug conjugate, immuno oncology, biotechnology, biopharmaceutical, antibodies, Discovery, Therapeutic Monoclonal Antibodies, Immunotoxins, Bispecific mAbs, Drug Screening, Drug Candidate Selection, In Vitro Cell-Based Assays, In Vivo Preclinical Animal Models, Cancer & Immunological Diseases, Validation of Cancer-Associated Targets
Industry
Profile
Address
Classification
Description
?Discovery & Preclinical Development of Therapeutic Monoclonal Antibodies, Immunotoxins, Bispecific mAbs, and Antibody-Drug Conjugates ?Drug Screening & Drug Candidate Selection using In Vitro Cell-Based Assays and In Vivo Preclinical Animal Models for Cancer & Immunological Diseases ?Conceiving & Advancing New Biological Technology Platforms ?Validation of Cancer-Associated Targets and Disease Association Analyses ?Optimization & Development of In Vitro and In Vivo Preclinical Models ?Preliminary Toxicology in Small Animals and Non-Human Primates
